Vimarsana
Biggest News Aggregation in the World

Page 18 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cellular Therapy Today - Breaking & Trending Today

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 ... - Vimarsana News

TScan Therapeutics Announces Best Abstracts Award and Upcoming Oral Presentation at the 2024 ...

Presentation to include additional results from ongoing Phase 1 study of TSC-100 and TSC-101 for the treatment of heme malignancies

Natco pharma picks up 5.38% stake in cell & gene therapy startup Cellogen Therapeutics - Vimarsana News

Natco pharma picks up 5.38% stake in cell & gene therapy startup Cellogen Therapeutics

India Business News: HYDERABAD: Natco Pharma Limited has picked up over 5% stake in Delhi-based biotech startup Cellogen Therapeutics Private Limited, which is working on .

San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry - Vimarsana News

San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry

SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco. The J.P. Morgan Healthcare Conference has...

San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry - Vimarsana News

San Francisco Witnesses the Voice of GCT Titans GenScript Biotech Global Forum Outlines the Future of the Industry

SAN FRANCISCO, Jan. 12, 2024 /PRNewswire/ -- Every January, the global medical health and financial investment sectors turn their focus to San Francisco.

ISCT Leads Global Scientific Consortia to Respond to Recent FDA Report on Risk of T-Cell Malignancy in Patients Following CAR T-Cell Immunotherapies - Vimarsana News

ISCT Leads Global Scientific Consortia to Respond to Recent FDA Report on Risk of T-Cell Malignancy in Patients Following CAR T-Cell Immunotherapies

/PRNewswire/ - The International Society for Cell & Gene Therapy (ISCT), the global society of clinicians, researchers, regulators, technologists, and industry...